PTPN1/2 inhibition induces highly functional terminal effector CD8 T cells through autocrine IL-10
L. A. Perez-Quintero, A. Poirier, Z. Martinez-Cordoba, C.-H. Feng, I. Aubry, C. Carli, S. Kamyabiazar, A. Pacis, Y. Zolotarov, K.-A. Pike, J.-S. Delisle, M. L. Tremblay
This study shows that inhibiting PTPN1/2 enhances CD8 T cell effector function via autocrine IL-10, suggesting a new strategy for cancer immunotherapy.
bioRxiv · Apr 17, 2023 · PreprintImmunology